A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Semler Scientific, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 20,858 shares of SMLR stock, worth $944,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,858
Holding current value
$944,867
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.21 $465,133 - $755,268
20,858 New
20,858 $491,000
Q1 2024

May 15, 2024

BUY
$28.42 - $51.54 $907,024 - $1.64 Million
31,915 New
31,915 $932,000
Q3 2023

Nov 14, 2023

SELL
$23.15 - $28.54 $327,595 - $403,869
-14,151 Reduced 52.06%
13,029 $330,000
Q2 2023

Aug 14, 2023

SELL
$22.5 - $30.58 $264,577 - $359,590
-11,759 Reduced 30.2%
27,180 $713,000
Q1 2023

May 15, 2023

BUY
$19.28 - $41.74 $750,743 - $1.63 Million
38,939 New
38,939 $1.04 Million
Q3 2022

Nov 14, 2022

BUY
$27.75 - $45.8 $614,773 - $1.01 Million
22,154 New
22,154 $832,000

Others Institutions Holding SMLR

About Semler Scientific, Inc.


  • Ticker SMLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 6,800,580
  • Market Cap $308M
  • Description
  • Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...
More about SMLR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.